How important is the duration of the brain death period for the outcome in kidney transplantation?

Transplant International

Volumn 24, Issue 1, 2011, Pages 14-20

  Nijboer, Willemijn N ^a,b   Moers, Cyril ^a,b   Leuvenink, Henri G D ^a   Ploeg, Rutger J ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

brain death duration; DGF; donor; kidney transplantation

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BRAIN DEATH; CARDIOVASCULAR RISK; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY;

ADULT; BRAIN DEATH; DELAYED GRAFT FUNCTION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT;

EID: 78649984643     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01150.x     Document Type: Article

References (27)

1. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S,. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333.
2. Matas AJ, Gillingham KJ, Humar A, Dunn DL, Sutherland DE, Najarian JS,. Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation 2000; 69: 54.
3. Roodnat JI, Van Riemsdijk IC, Mulder PG, et al. The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis. Transplantation 2003; 75: 2014.
4. Jones JW Jr, Gillingham KJ, Sutherland DE, et al. Successful long-term outcome with 0-haplotype-matched living-related kidney donors. Transplantation 1994; 57: 512.
5. Sanchez-Fructuoso AI, Prats D, Marques M, et al. Does donor brain death influence acute vascular rejection in the kidney transplant? Transplantation 2004; 78: 142.
6. Van Der Hoeven JA, Molema G, Ter Horst GJ, et al. Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 2003; 64: 1874.
7. Bos EM, Schuurs TA, Kraan M, et al. Renal expression of heat shock proteins after brain death induction in rats. Transplant Proc 2005; 37: 359.
8. Avlonitis VS, Wigfield CH, Golledge HD, Kirby JA, Dark JH,. Early hemodynamic injury during donor brain death determines the severity of primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7: 83.
9. Kunzendorf U, Hohenstein B, Oberbarnscheid M, et al. Duration of donor brain death and its influence on kidney graft function. Am J Transplant 2002; 2: 292.
10. Morrissey PE, Gohh R, Yango A, Gautam A, Monaco AP,. Renal transplant survival from older donors: a single center experience. Arch Surg 2004; 139: 384.
11. Kasiske BL, Snyder J,. Matching older kidneys with older patients does not improve allograft survival. J Am Soc Nephrol 2002; 13: 1067.
12. Goldfarb-Rumyantzev AS, Scandling JD, Pappas L, Smout RJ, Horn S,. Prediction of 3-yr cadaveric graft survival based on pre-transplant variables in a large national dataset. Clin Transplant 2003; 17: 485.
13. Issa N, Stephany B, Fatica R, et al. Donor factors influencing graft outcomes in live donor kidney transplantation. Transplantation 2007; 83: 593.
14. Salahudeen AK, Haider N, May W,. Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int 2004; 65: 713.
15. McLaren AJ, Jassem W, Gray DW, Fuggle SV, Welsh KI, Morris PJ,. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 1999; 13: 266.
16. Neylan JF,. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine FK506 Kidney Transplant Study Group. Transplantation 1998; 65: 515.
17. Merion RM, Ashby VB, Wolfe RA, et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005; 294: 2726.
18. Ojo AO, Leichtman AB, Punch JD, et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000; 36: 153.
19. Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360: 7.
20. Schold JD, Kaplan B, Howard RJ, Reed AI, Foley DP, Meier-Kriesche HU,. Are we frozen in time? Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation. Am J Transplant 2005; 5: 1681.
21. Giral M, Bertola JP, Foucher Y, et al. Effect of brain-dead donor resuscitation on delayed graft function: results of a monocentric analysis. Transplantation 2007; 83: 1174.
22. Nijboer WN, Schuurs TA, Van Der Hoeven JA, et al. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation 2004; 78: 978.
23. Kusaka M, Yamada K, Kuroyanagi Y, et al. Gene expression profile in rat renal isografts from brain dead donors. Transplant Proc 2005; 37: 364.
24. Bos EM, Leuvenink HG, Van Goor H, Ploeg RJ,. Kidney grafts from brain dead donors: inferior quality or opportunity for improvement? Kidney Int 2007; 72: 797.
25. Hoeger S, Reisenbuechler A, Gottmann U, et al. Donor dopamine treatment in brain dead rats is associated with an improvement in renal function early after transplantation and a reduction in renal inflammation. Transpl Int 2008; 21: 1072.
26. Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA 2009; 302: 1067.
27. Cohen B, D'Amaro J, De MJ, Persijn GG,. Changing patterns in organ donation in Eurotransplant, 1990-1994. Transpl Int 1997; 10: 1.